← All articles

CDC 7-Day Rule: HIV Testing Before Starting PrEP

Carlos Rangel
CDC 7-Day Rule: HIV Testing Before Starting PrEP
The CDC 7-day rule requires a negative HIV test within 7 days before your first PrEP dose. Here's the test-to-start workflow clinics use.

Table of Contents

Last Updated: October 8, 2026

What the CDC 7-Day Rule Actually Requires Before PrEP

The CDC 7 day rule HIV testing before starting PrEP means one thing in practice: a patient needs a documented negative HIV test taken within the seven days before their first dose of pre-exposure prophylaxis. That is the whole rule. Everything else is workflow.

This guide from The Marketing Lab covers how clinics actually satisfy that window without slowing down the visit.

Key Takeaway The seven days is a test-to-first-dose window, not a protection timeline. A negative test on Monday and a first dose on Friday satisfies the rule. A negative test on Monday and a first dose two weeks later does not.

Why the Window Exists: Acute HIV and Drug Resistance

The window exists because of acute HIV infection. A person recently exposed can test negative on an antibody-based test and still carry the virus. Starting PrEP during that blind spot means the drug is the only thing in their system, and HIV can develop resistance to it.

CDC guidance on HIV testing before PrEP initiation treats a documented negative test inside the window as the minimum safeguard. The rule is not administrative box-checking. It is the difference between prevention and a resistant infection that is much harder to treat.

Key points for staff:

  • A negative test older than seven days does not satisfy the rule
  • The test must be documented before the first dose, not after
  • Acute infection symptoms change the pathway entirely

Rapid HIV Test Before Starting PrEP: What Counts as a Valid Negative

A rapid HIV test before starting PrEP counts as valid when it is a blood-based, CLIA-waived test performed and documented in the encounter, with a negative result inside the seven-day window. A fingerstick rapid test at rooming is the workhorse here because it returns a result in minutes and lets the visit move forward the same day.

What does not count:

  • A patient's verbal report of a recent negative test elsewhere
  • A scanned PDF in the chart with no structured result
  • An at-home test with no documentation in the record

At-Home, Rapid, and Laboratory Tests: Which Satisfies the Rule

Laboratory testing carries the strongest documentation, but it takes time. A fourth-generation antigen/antibody test with reflex RNA drawn against an open order confirms status within 24 to 48 hours. That is too slow for a same-day start unless a rapid test covers the window in the meantime.

Here is how the three options compare:

Test type Turnaround Satisfies the 7-day rule? Best use
Rapid fingerstick Minutes Yes, if documented in the encounter Same-day start
Lab Ag/Ab with reflex RNA 24-48 hours Yes, once resulted Confirmation and baseline
At-home kit Days Only with a structured result in the chart Not for same-day start
Pro Tip Run the rapid test at rooming, not after the provider sees the patient. By the time the provider walks in, the result is in the chart and the prescription or first injection can go out the door on the same visit.

Same-Day PrEP Start Workflow: From Rooming to First Dose

Same-day start works when the rapid test is built into rooming rather than added as a separate task. The medical assistant performs the fingerstick, the result posts to the chart, and the provider reviews it before the exam.

Workflow diagram of a medical assistant performing a rapid HIV test to follow the CDC 7 day rule for starting PrEP
Workflow diagram of a medical assistant performing a rapid HIV test to follow the CDC 7 day rule for starting PrEP

The sequence that holds up:

  1. Room the patient and complete the rapid HIV test
  2. Document the result in the encounter, not in a staff note
  3. Draw the baseline panel against the open order
  4. Review the negative rapid result with the provider
  5. Write the prescription or give the first injection
  6. Book the next visit before the patient leaves

That last step matters more than most clinics treat it. A same-day start with no booked follow-up is a start that quietly lapses.

A Day-by-Day Timeline From Test to First Dose

The seven-day window is easier to run when staff can see it on a calendar. Here is what a clean same-day start looks like, and what changes when the visit slips.

Day Action Rule status
Day 0 (visit) Rapid HIV at rooming, negative; baseline panel drawn; first dose given Satisfied, test and dose same day
Day 1-6 Patient starts medication at home (oral) or returns for injection Still satisfied, dose inside window
Day 7 Last day a first dose can go on the Day 0 test Satisfied, edge of window
Day 8+ First dose has not happened Not satisfied, repeat HIV test before starting

What To Do When the Start Is Delayed Past Seven Days

Delays happen: the pharmacy is out of stock, the patient reschedules, the prior authorization on injectable PrEP drags. The rule does not bend for any of those reasons.

  • If the first dose has not been given by day 7, repeat the HIV test before starting, do not rely on the original result
  • If the delay was more than a few weeks and the patient reports ongoing risk, treat it as a new baseline: rapid test at rooming, full panel against a fresh open order
  • If the patient was already taking oral PrEP and simply missed doses, that is an adherence conversation, not a new baseline, confirm HIV status per the follow-up cadence
  • Document the reason for the delay in the encounter so the chart shows why a second test was drawn

The Protection Timeline Is a Separate Clock

A negative test inside seven days clears the patient to start. It does not mean the patient is protected on day one. Oral PrEP reaches maximum protection after roughly seven days of consistent dosing for receptive anal sex and longer for other exposure routes; injectable PrEP has its own lead-in schedule.

That distinction matters for counseling. A patient who starts PrEP on Friday and has condomless sex on Saturday is not yet at full protection. Pair the start with a plain-language conversation about the lead-in period and, where appropriate, a bridge strategy.

Pro Tip Build the timeline into the visit template. When the MA, the provider and the front desk all see the same day-count, the seven-day rule stops being a policy and becomes a step in the rooming workflow.

Operational Notes From Programs We Run

In our experience, the clinics that hold the window most reliably share three habits: (Source: CDC's comprehensive guide to HIV testing)

Book a Free Strategy Call →

  • The rapid test is a rooming task, not a provider task, so it never competes with exam time
  • The baseline panel is drawn against an open order at the same visit, so results land as structured data
  • The next visit is booked before the patient leaves, with automatic rebooking at the clinical cadence in the CRM

For injectable PrEP, the same-day start has an extra failure point: an injection given at an appointment that was never checked in produces no encounter, no note and no charge. Standardize an injection order set so the drug, the administration and the HIV result all land on the same claim.

PrEP Baseline Labs CPT Codes and the Full Panel

The baseline panel is drawn at the same visit as the rapid test, against an open lab order. Every result must land as a structured value in the EHR. Scanned results are invisible to reports and useless for follow-up.

Test CPT code
HIV Ag/Ab 87389
HIV-1 RNA 87536
Hepatitis B surface antigen 87340
Hepatitis B surface antibody 86706
Hepatitis C antibody 86803
Comprehensive metabolic panel 80053
Urinalysis 81003
Pregnancy test 81025
Syphilis 86592
Chlamydia / gonorrhea 87491 / 87591
Trichomonas 87661
Watch Out Baseline evaluation is not complete until every result is filed as structured data. A scanned lab PDF in the chart looks like documentation but produces no result, no flag and no follow-up trigger.

PrEP Open Lab Order Follow-Up: Who Owns the Result

Every open lab order needs a named owner, and that owner should be the prescriber who ordered it. This is the step where programs quietly break. The order goes out, the patient leaves, and nobody checks whether the result came back.

What works in programs we run:

  • Each prescriber reviews their own open orders weekly
  • A monthly overdue list pulls anyone on a PrEP medication with no HIV test in 90 days
  • A named staff member works the recall list, not an automated reminder alone

Pending, Indeterminate, and Discordant Results

A pending result is not a negative result. Until the lab reports back, the rapid test is what carries the visit, and the open order needs a scheduled review.

Discordant results stop everything. If the antigen/antibody test and the RNA test disagree, treat it as possible acute infection until proven otherwise. Hold PrEP, repeat testing, and link the patient to care. The same applies to an indeterminate result.

Key Takeaway A positive or discordant result does not just pause PrEP. It triggers linkage to HIV care, and that handoff needs a named person on both ends.

Follow-Up Cadence and Ongoing HIV Monitoring on PrEP

Follow-up cadence depends on the regimen, and the cadence is what keeps the program defensible. Oral PrEP needs a visit every three months with an HIV test and STI screen, plus renal function every six to twelve months.

Injectable PrEP runs on its own clock:

  • Apretude: month 1, month 2, then every 2 months
  • Yeztugo: lead-in doses, then every 6 months

Lapsed injections need a weekly recall worklist with a named owner. Automated reminders alone fail silently. When dose 2 slips past a month, check the reinitiation rules before the next injection.

Common Mistakes Clinics Make With the 7-Day Rule

The mistakes are predictable, and most of them are documentation problems rather than clinical ones.

  • Treating a patient's reported outside test as documentation
  • Filing a scanned lab result instead of a structured value
  • Letting the rapid test happen after the provider visit
  • Starting PrEP on a pending result
  • Leaving the next visit unbooked
  • Skipping the RNA draw when recent exposure is reported
Pro Tip In our experience, the single highest-yield fix is moving the rapid test into rooming. It shortens the visit, satisfies the rule on the spot, and removes the temptation to start PrEP on a result that has not come back yet.

Conclusion: Build the Rule Into the Visit, Not Around It

The CDC 7 day rule HIV testing before starting PrEP is simple to state and easy to break in a busy clinic. The fix is not more policy.

That is the kind of infrastructure The Marketing Lab builds for clinics.

Get started with The Marketing Lab and build a PrEP workflow where the seven-day rule is a step in the visit, not an afterthought. Book a free 30-minute strategy call at https://thelab.marketing/schedule.

Frequently Asked Questions

What is the CDC 7-day rule for HIV testing before starting PrEP?

It means a patient needs a documented negative HIV test collected within the 7 days before their first PrEP dose. A rapid HIV test at rooming satisfies that requirement, so the prescription or first injection can go the same day. A 4th-generation antigen/antibody test drawn against an open order confirms the result within 24 to 48 hours. PrEP is not started if that test comes back positive or discordant.

Can a rapid HIV test allow a patient to start PrEP the same day?

Yes. A CLIA-waived rapid HIV test performed at rooming gives you a documented negative result inside the 7-day window, which is what the rule requires. Draw the confirmatory 4th-generation Ag/Ab with reflex RNA at the same visit against an open lab order, and have a named provider review it within 24 to 48 hours. If the confirmatory result is positive or discordant, stop PrEP and trigger linkage to care.

What baseline labs and CPT codes should a PrEP visit include?

A standard baseline panel includes HIV Ag/Ab (87389), HIV-1 RNA (87536) when acute infection is suspected, HBsAg (87340), anti-HBs (86706), HCV antibody (86803), CMP (80053), urinalysis (81003), pregnancy test (81025), syphilis (86592), chlamydia/gonorrhea NAAT (87491/87591), and trichomonas (87661). Code the visit as preventive with Z29.81 and Z11.3 or Z11.4, never diagnostic, so the labs stay at $0 cost-sharing under ACA section 2713.

How should a clinic handle pending, indeterminate, or discordant results?

Hold or stop PrEP until the result resolves. A positive or discordant 4th-generation Ag/Ab with reflex RNA means possible acute HIV infection: do not continue PrEP, order HIV-1 RNA if not already drawn, and link the patient to HIV care the same day. Pending results need a named owner and a weekly worklist. In our experience, open lab orders with no assigned reviewer are the single most common reason a PrEP start stalls or a patient stays on medication they should have paused.

Want this for your clinic?

Bring us your patient acquisition, 340B program, or compliance bottleneck. We will show you what a 30-day launch looks like for your clinic — in English or Spanish, month to month, no long contract.